{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:05:37Z","timestamp":1790186737047,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82374386"],"award-info":[{"award-number":["82374386"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.diabres.2026.113525","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:50:51Z","timestamp":1787669451000},"page":"113525","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Colquhounia Root Tablet as an immune-metabolic adjunct for residual kidney risk in heavy-proteinuric type 2 diabetic kidney disease: a propensity-score-matched real-world study"],"prefix":"10.1016","volume":"240","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7260-8058","authenticated-orcid":false,"given":"Lin","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenchen","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangyi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1 Suppl 1","key":"10.1016\/j.diabres.2026.113525_b0005","doi-asserted-by":"crossref","first-page":"A6","DOI":"10.1053\/j.ajkd.2019.09.003","article-title":"US Renal Data System 2019 Annual Data Report: Epidemiology of Kidney Disease in the United States","volume":"75","author":"Saran","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"9981","key":"10.1016\/j.diabres.2026.113525_b0010","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/S0140-6736(14)61601-9","article-title":"Worldwide access to treatment for end-stage kidney disease: a systematic review","volume":"385","author":"Liyanage","year":"2015","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.diabres.2026.113525_b0015","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/BF02374503","article-title":"Determinants of end-stage renal disease in Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus and proteinuria","volume":"36","author":"Nelson","year":"1993","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2026.113525_b0020","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee. 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes-2025. Diabetes Care 2025, 48(Supplement_1): S239-S251. doi: 10.2337\/dc25-S011.","DOI":"10.2337\/dc25-S011"},{"issue":"9","key":"10.1016\/j.diabres.2026.113525_b0025","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.2337\/dci23-0030","article-title":"Diabetic Nephropathy: Update on Pillars of Therapy slowing Progression","volume":"46","author":"Naaman","year":"2023","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.diabres.2026.113525_b0030","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41581-019-0234-4","article-title":"Innate immunity in diabetic kidney disease","volume":"16","author":"Tang","year":"2020","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"10.1016\/j.diabres.2026.113525_b0035","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/ki.2013.276","article-title":"Therapeutic use of traditional chinese herbal medications for chronic kidney diseases","volume":"84","author":"Zhong","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.diabres.2026.113525_b0040","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.2147\/DDDT.S488557","article-title":"Efficacy and Safety of Colquhounia root Tablet for Chronic Glomerulopathy: a Real-World Survey with Bioinformatics Insights","volume":"19","author":"Liu","year":"2025","journal-title":"Drug Des Devel Ther"},{"issue":"5","key":"10.1016\/j.diabres.2026.113525_b0045","first-page":"418","article-title":"Clinical study on treatment of childhood Henoch\u2013Schonlein purpura nephritis with colquhounia root tablet","volume":"24","author":"Zhou","year":"2004","journal-title":"Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi"},{"issue":"2","key":"10.1016\/j.diabres.2026.113525_b0050","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s11255-023-03682-2","article-title":"Colquhounia root tablet in the treatment of idiopathic membranous nephropathy with subnephrotic proteinuria","volume":"56","author":"Xu","year":"2024","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.diabres.2026.113525_b0055","doi-asserted-by":"crossref","DOI":"10.1007\/s11655-014-1688-7","article-title":"Effect and safety of Tripterygium Hypoglaucum (L\u00e9vl.) hutch in treating proteinuria of kidney transplant recipients","author":"Yuan","year":"2014","journal-title":"Chin J Integr Med Epub ahead of print"},{"issue":"01","key":"10.1016\/j.diabres.2026.113525_b0060","article-title":"The systematic evaluation and Meta-analysis of treating diabetic kidney disease with the Huobahua Gen tablets. Clinical","volume":"14","author":"Xiong","year":"2022","journal-title":"Journal of Chinese Medicine"},{"key":"10.1016\/j.diabres.2026.113525_b0065","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1166880","article-title":"Huobahuagen tablet improves renal function in diabetic kidney disease: a real-world retrospective cohort study","volume":"14","author":"Tan","year":"2023","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.diabres.2026.113525_b0070","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.cca.2018.04.004","article-title":"A metabolomics study on the immunosuppressive effect of Tripterygium hypoglaucum (Levl.) Hutch in mice: the discovery of pathway differences in serum metabolites","volume":"483","author":"Guo","year":"2018","journal-title":"Clinica chimica acta; international journal of clinical chemistry"},{"issue":"1","key":"10.1016\/j.diabres.2026.113525_b0075","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jep.2013.10.045","article-title":"Total alkaloids of Tripterygium hypoglaucum (levl.) Hutch inhibits tumor growth both in vitro and in vivo","volume":"151","author":"Jiang","year":"2014","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.diabres.2026.113525_b0080","article-title":"Tripterygium hypoglaucum (L\u00e9vl.) Hutch and its Main Bioactive Components: recent advances in Pharmacological activity","volume":"12","author":"Zhao","year":"2021","journal-title":"Pharmacokinetics and Potential Toxicity Frontiers in pharmacology"},{"key":"10.1016\/j.diabres.2026.113525_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109599","article-title":"Tripterygium and its extracts for diabetic nephropathy: Efficacy and pharmacological mechanisms","volume":"121","author":"Huang","year":"2020","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.diabres.2026.113525_b0090","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s13643-022-02091-3","article-title":"Efficacy and safety of Tripterygium wilfordii polyglycosides for diabetic kidney disease: an overview of systematic reviews and meta-analyses","volume":"11","author":"Wang","year":"2022","journal-title":"Syst Rev"},{"issue":"2","key":"10.1016\/j.diabres.2026.113525_b0095","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/jat.4532","article-title":"Subchronic toxicity evaluation of Huobahuagen extract and plasma metabolic profiling analysis combined with conventional pathology methods","volume":"44","author":"Long","year":"2024","journal-title":"J Appl Toxicol"},{"issue":"Suppl 1","key":"10.1016\/j.diabres.2026.113525_b0100","first-page":"S15","article-title":"2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021","volume":"44","author":"Committee","year":"2021","journal-title":"Diabetes Care"},{"issue":"4S","key":"10.1016\/j.diabres.2026.113525_b0105","first-page":"S1","volume":"98","year":"2020","journal-title":"Kidney Int"},{"issue":"10","key":"10.1016\/j.diabres.2026.113525_b0110","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.2337\/dc14-1296","article-title":"Diabetic kidney disease: a report from an ADA Consensus Conference","volume":"37","author":"Tuttle","year":"2014","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.diabres.2026.113525_b0115","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1053\/j.ajkd.2014.07.030","article-title":"GFR decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration","volume":"64","author":"Levey","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.diabres.2026.113525_b0120","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1053\/j.ajkd.2014.08.017","article-title":"GFR decline as an alternative end point to kidney failure in clinical trials: a meta-analysis of treatment effects from 37 randomized trials","volume":"64","author":"Inker","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1016\/j.diabres.2026.113525_b0125","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline","volume":"158","author":"Stevens","year":"2013","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.diabres.2026.113525_b0130","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.2337\/dc20-1622","article-title":"Changes in Albuminuria Predict Cardiovascular and Renal Outcomes in Type 2 Diabetes: a Post Hoc Analysis of the LEADER Trial","volume":"44","author":"Persson","year":"2021","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.diabres.2026.113525_b0135","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/0962280206074463","article-title":"Multiple imputation of discrete and continuous data by fully conditional specification","volume":"16","author":"van Buuren","year":"2007","journal-title":"Stat Methods Med Res"},{"issue":"1","key":"10.1016\/j.diabres.2026.113525_b0140","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41591-024-03327-6","article-title":"Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial","volume":"31","author":"Apperloo","year":"2025","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.diabres.2026.113525_b0145","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity Analysis in Observational Research: introducing the E-Value","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"issue":"24","key":"10.1016\/j.diabres.2026.113525_b0150","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.diabres.2026.113525_b0155","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of Semaglutide on Chronic Kidney Disease in patients with Type 2 Diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.diabres.2026.113525_b0160","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.diabres.2026.113525_b0165","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.fitote.2011.02.011","article-title":"Triptolide ameliorates Crohn's colitis is associated with inhibition of TLRs\/NF-kappaB signaling pathway","volume":"82","author":"Yu","year":"2011","journal-title":"Fitoterapia"},{"issue":"1","key":"10.1016\/j.diabres.2026.113525_b0170","doi-asserted-by":"crossref","DOI":"10.1080\/0886022X.2023.2165103","article-title":"Triptolide protects against podocyte injury in diabetic nephropathy by activating the Nrf2\/HO-1 pathway and inhibiting the NLRP3 inflammasome pathway","volume":"45","author":"Lv","year":"2023","journal-title":"Ren Fail"},{"key":"10.1016\/j.diabres.2026.113525_b0175","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1030278","article-title":"Combining bioinformatics, network pharmacology and artificial intelligence to predict the mechanism of celastrol in the treatment of type 2 diabetes","volume":"13","author":"Wu","year":"2022","journal-title":"Front Endocrinol"},{"issue":"12","key":"10.1016\/j.diabres.2026.113525_b0180","doi-asserted-by":"crossref","first-page":"10800","DOI":"10.1002\/fsn3.4617","article-title":"Epigallocatechin-3-Gallate Ameliorates Diabetic Kidney Disease by Inhibiting the TXNIP\/NLRP3\/IL-1\u03b2 Signaling Pathway","volume":"12","author":"Wang","year":"2024","journal-title":"Food Sci Nutr"},{"issue":"4","key":"10.1016\/j.diabres.2026.113525_b0185","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1039\/D0NP00054J","article-title":"Triptolide: reflections on two decades of research and prospects for the future","volume":"38","author":"Tong","year":"2021","journal-title":"Nat Prod Rep"},{"issue":"5","key":"10.1016\/j.diabres.2026.113525_b0190","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/j.1939-4640.2000.tb02137.x","article-title":"Long-term effects of triptolide on spermatogenesis, epididymal sperm function, and fertility in male rats","volume":"21","author":"Huynh","year":"2000","journal-title":"J Androl"},{"issue":"1","key":"10.1016\/j.diabres.2026.113525_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/01480541003774358","article-title":"Triptolide induces adverse effect on reproductive parameters of female Sprague-Dawley rats","volume":"34","author":"Liu","year":"2011","journal-title":"Drug Chem Toxicol"},{"key":"10.1016\/j.diabres.2026.113525_b0200","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.biopha.2017.04.003","article-title":"Toxicity of triptolide and the molecular mechanisms involved","volume":"90","author":"Xi","year":"2017","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"10.1016\/j.diabres.2026.113525_b0205","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3736\/jcim20050509","article-title":"Clinical observation on treatment of IgA nephropathy with Huobahuagen Tablets and irbesartan","volume":"3","author":"Guan","year":"2005","journal-title":"Zhong Xi Yi Jie He Xue Bao"},{"issue":"1","key":"10.1016\/j.diabres.2026.113525_b0210","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70133","article-title":"Machine learning-based multi-omics models for diagnostic classification and risk stratification in diabetic kidney disease","volume":"15","author":"Shao","year":"2025","journal-title":"Clin Transl Med"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726004456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726004456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:25:30Z","timestamp":1790184330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822726004456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":42,"alternative-id":["S0168822726004456"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113525","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Colquhounia Root Tablet as an immune-metabolic adjunct for residual kidney risk in heavy-proteinuric type 2 diabetic kidney disease: a propensity-score-matched real-world study","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113525","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113525"}}